GB9808599D0 - Improvements in or realting to contrast agents - Google Patents

Improvements in or realting to contrast agents

Info

Publication number
GB9808599D0
GB9808599D0 GBGB9808599.6A GB9808599A GB9808599D0 GB 9808599 D0 GB9808599 D0 GB 9808599D0 GB 9808599 A GB9808599 A GB 9808599A GB 9808599 D0 GB9808599 D0 GB 9808599D0
Authority
GB
United Kingdom
Prior art keywords
dispersed
gas
preparations
perfusion
material present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9808599.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
Original Assignee
Nycomed Imaging AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging AS filed Critical Nycomed Imaging AS
Priority to GBGB9808599.6A priority Critical patent/GB9808599D0/en
Publication of GB9808599D0 publication Critical patent/GB9808599D0/en
Priority to JP2000544366A priority patent/JP2002512206A/ja
Priority to DE69937341T priority patent/DE69937341D1/de
Priority to HU0102878A priority patent/HUP0102878A3/hu
Priority to BR9909822-9A priority patent/BR9909822A/pt
Priority to PCT/GB1999/001221 priority patent/WO1999053963A1/en
Priority to AT99918133T priority patent/ATE375806T1/de
Priority to PL99343464A priority patent/PL343464A1/xx
Priority to AU36172/99A priority patent/AU3617299A/en
Priority to EP99918133A priority patent/EP1073473B1/en
Priority to KR1020007011727A priority patent/KR20010042915A/ko
Priority to CN99807622A priority patent/CN1306442A/zh
Priority to CA002329175A priority patent/CA2329175A1/en
Priority to IL13914799A priority patent/IL139147A0/xx
Priority to ZA200005789A priority patent/ZA200005789B/xx
Priority to NO20005250A priority patent/NO20005250L/no
Priority to US10/717,196 priority patent/US20040146462A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasonic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasonic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Acoustics & Sound (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Light Receiving Elements (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB9808599.6A 1998-04-22 1998-04-22 Improvements in or realting to contrast agents Ceased GB9808599D0 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
GBGB9808599.6A GB9808599D0 (en) 1998-04-22 1998-04-22 Improvements in or realting to contrast agents
IL13914799A IL139147A0 (en) 1998-04-22 1999-04-22 Improvements in or relating to contrast agents
AU36172/99A AU3617299A (en) 1998-04-22 1999-04-22 Improvements in or relating to contrast agents
KR1020007011727A KR20010042915A (ko) 1998-04-22 1999-04-22 조영제 또는 그와 관련된 개선
HU0102878A HUP0102878A3 (en) 1998-04-22 1999-04-22 Improvements in or relating to contrast agents
BR9909822-9A BR9909822A (pt) 1998-04-22 1999-04-22 Preparação combinada para uso simultâneo, separado ou sequencial como um agente de contraste em produção de imagem por ultra-som, e, processo de gerar imagens acentuadas de um indivìduo animal humano ou não humano
PCT/GB1999/001221 WO1999053963A1 (en) 1998-04-22 1999-04-22 Improvements in or relating to contrast agents
AT99918133T ATE375806T1 (de) 1998-04-22 1999-04-22 Verbesserungen in oder bezüglich zu kontrastmittel
PL99343464A PL343464A1 (en) 1998-04-22 1999-04-22 Improvements in or relating to contrast agents
JP2000544366A JP2002512206A (ja) 1998-04-22 1999-04-22 改良された造影剤
EP99918133A EP1073473B1 (en) 1998-04-22 1999-04-22 Improvements in or relating to contrast agents
DE69937341T DE69937341D1 (de) 1998-04-22 1999-04-22 Verbesserungen in oder bezüglich zu kontrastmittel
CN99807622A CN1306442A (zh) 1998-04-22 1999-04-22 造影剂或与造影剂有关的改进
CA002329175A CA2329175A1 (en) 1998-04-22 1999-04-22 Improvements in or relating to contrast agents
ZA200005789A ZA200005789B (en) 1998-04-22 2000-10-18 Ultrasound contrast agents useful as deposited perfusion tracers.
NO20005250A NO20005250L (no) 1998-04-22 2000-10-19 Kontrastmiddel
US10/717,196 US20040146462A1 (en) 1998-04-22 2003-11-19 Contrast agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9808599.6A GB9808599D0 (en) 1998-04-22 1998-04-22 Improvements in or realting to contrast agents

Publications (1)

Publication Number Publication Date
GB9808599D0 true GB9808599D0 (en) 1998-06-24

Family

ID=10830802

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9808599.6A Ceased GB9808599D0 (en) 1998-04-22 1998-04-22 Improvements in or realting to contrast agents

Country Status (17)

Country Link
US (1) US20040146462A1 (https=)
EP (1) EP1073473B1 (https=)
JP (1) JP2002512206A (https=)
KR (1) KR20010042915A (https=)
CN (1) CN1306442A (https=)
AT (1) ATE375806T1 (https=)
AU (1) AU3617299A (https=)
BR (1) BR9909822A (https=)
CA (1) CA2329175A1 (https=)
DE (1) DE69937341D1 (https=)
GB (1) GB9808599D0 (https=)
HU (1) HUP0102878A3 (https=)
IL (1) IL139147A0 (https=)
NO (1) NO20005250L (https=)
PL (1) PL343464A1 (https=)
WO (1) WO1999053963A1 (https=)
ZA (1) ZA200005789B (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804162A (en) * 1995-06-07 1998-09-08 Alliance Pharmaceutical Corp. Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
DE10119522A1 (de) * 2001-04-20 2002-12-05 Innovacell Biotechnologie Gmbh Herstellung und Anwendung einer Suspensionszusammensetzung mit einem Ultraschall-Kontrastmittel
KR101280760B1 (ko) 2002-11-29 2013-07-05 지이 헬스케어 에이에스 초음파 조영 물질
US20070128117A1 (en) * 2003-02-04 2007-06-07 Bracco International B.V. Ultrasound contrast agents and process for the preparation thereof
JP4670083B2 (ja) 2003-02-04 2011-04-13 ブラッコ・シュイス・ソシエテ・アノニム 超音波造影剤およびその製造方法
JP2007515471A (ja) * 2003-12-22 2007-06-14 ブラッコ・リサーチ・ソシエテ・アノニム 造影イメージング用の活性成分を有する気体封入マイクロベシクルのアセンブリー
CN100563718C (zh) * 2003-12-22 2009-12-02 伯拉考开发股份有限公司 用于反差成像的充气微囊组件
US9248204B2 (en) 2004-08-18 2016-02-02 Bracco Suisse S.A. Gas-filled microvesicles composition for contrast imaging
US8153435B1 (en) 2005-03-30 2012-04-10 Tracer Detection Technology Corp. Methods and articles for identifying objects using encapsulated perfluorocarbon tracers
CN100453050C (zh) * 2005-09-21 2009-01-21 北京市肿瘤防治研究所 提高超声造影图像分辨力的方法和超声造影成像仪
US20080255266A1 (en) * 2007-04-10 2008-10-16 Gc Corporation Dental paste composition having x-ray imaging property
JP4279328B2 (ja) * 2007-05-07 2009-06-17 株式会社日立製作所 超音波撮像システム
WO2009097277A1 (en) * 2008-02-01 2009-08-06 Trustees Of Boston University Cationic contrast agents and methods of use thereof
AU2009241762B2 (en) * 2008-05-02 2015-07-16 Celsense Inc. Compositions and methods for producing emulsions for nuclear magnetic resonance techniques and other applications
EP2470287A4 (en) 2009-08-28 2015-01-21 Univ Columbia SYSTEMS, METHODS AND DEVICES FOR PRODUCING GAS-FILLED MICROBUBBLES
DE102011005444A1 (de) * 2011-03-11 2012-09-13 Innora Gmbh Festes, negatives Röntgenkontrastmittel zur Darstellung des Gastrointestinaltraktes
HUE060034T2 (hu) * 2013-09-27 2023-01-28 Exact Therapeutics As Ultrahanggal közvetített hatóanyag leadás
AP2016009276A0 (en) 2013-12-19 2016-06-30 Bayer Pharma AG Substituted piperidinyl-tetrahydroquinolines and their use as alpha-2c adrenoreceptor antagonists
CN110913769A (zh) * 2017-07-09 2020-03-24 利兰斯坦福初级大学董事会 利用频谱合成来减少斑点的超声成像
EP3678712A4 (en) * 2017-09-07 2021-06-02 Imbiotechnologies Ltd. EMBOLIC AGENTS SENSITIVE TO SOUND
CN108586300B (zh) * 2018-03-28 2020-03-17 成都福柯斯医药技术有限公司 一种s-碘化丁酰硫代胆碱的合成方法
CN114760989A (zh) 2019-10-25 2022-07-15 精准医疗股份有限公司 胰腺癌的治疗
GB2595513B (en) 2020-05-29 2023-03-29 Act Therapeutics Ltd Treatment of infections
US11801058B2 (en) * 2021-03-04 2023-10-31 Accumedical Beijing Ltd. Liquid embolic compositions
GB2605422B (en) 2021-03-31 2025-04-30 Act Therapeutics Ltd Treatment of the central nervous system
GB2629999B (en) 2021-04-21 2025-03-26 Act Therapeutics Ltd Enhancement of treatment with immunotherapeutic agents
CN113598820B (zh) * 2021-08-18 2025-09-23 南京超微影医疗科技有限公司 超声成像方法及装置
EP4261786A1 (en) * 2022-03-28 2023-10-18 Tata Consultancy Services Limited Methods and system for low dose x ray computed tomography perfusion imaging
NO20221187A1 (en) 2022-11-04 2024-05-06 Exact Therapeutics As Method and system for calculating a point estimate of an ultrasound dose
CN116271187B (zh) * 2023-03-21 2025-07-04 湖北科技学院 双模态显影温敏Pickering乳液介入栓塞材料及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580575A (en) * 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5228446A (en) * 1989-12-22 1993-07-20 Unger Evan C Gas filled liposomes and their use as ultrasonic contrast agents
US5776429A (en) * 1989-12-22 1998-07-07 Imarx Pharmaceutical Corp. Method of preparing gas-filled microspheres using a lyophilized lipids
US5716597A (en) * 1993-06-04 1998-02-10 Molecular Biosystems, Inc. Emulsions as contrast agents and method of use
EP1550464A1 (en) * 1993-07-30 2005-07-06 IMCOR Pharmaceutical Co. Stabilized microbubble composition for ultrasound
NO940711D0 (no) * 1994-03-01 1994-03-01 Nycomed Imaging As Preparation of gas-filled microcapsules and contrasts agents for diagnostic imaging
US5846517A (en) * 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
TR199901544T2 (xx) * 1996-10-21 1999-09-21 Nycomed Imaging As Kontrast ajanlar�ndaki veya kontrast ajanlar�yla ilgili geli�meler.
EP0963209A2 (en) * 1996-10-28 1999-12-15 Marsden, John Christopher Improvements in or relating to diagnostic/therapeutic agents
EP0991427A2 (en) * 1996-10-28 2000-04-12 Marsden, John Christopher Improvements in or relating to diagnostic/therapeutic agents
WO1998018497A2 (en) * 1996-10-28 1998-05-07 Nycomed Imaging As Contrast agents

Also Published As

Publication number Publication date
CN1306442A (zh) 2001-08-01
JP2002512206A (ja) 2002-04-23
US20040146462A1 (en) 2004-07-29
HUP0102878A2 (hu) 2002-03-28
AU3617299A (en) 1999-11-08
DE69937341D1 (de) 2007-11-29
NO20005250D0 (no) 2000-10-19
BR9909822A (pt) 2000-12-19
PL343464A1 (en) 2001-08-13
ZA200005789B (en) 2001-07-30
CA2329175A1 (en) 1999-10-28
ATE375806T1 (de) 2007-11-15
WO1999053963A1 (en) 1999-10-28
KR20010042915A (ko) 2001-05-25
IL139147A0 (en) 2001-11-25
EP1073473A1 (en) 2001-02-07
NO20005250L (no) 2000-12-18
HUP0102878A3 (en) 2002-12-28
EP1073473B1 (en) 2007-10-17

Similar Documents

Publication Publication Date Title
GB9808599D0 (en) Improvements in or realting to contrast agents
WO1998017324A3 (en) Improvements in or relating to contrast agents
WO2004017907A3 (en) Blood clot-targeted nanoparticles
ATE113832T1 (de) Im wasser schnell suspendierbare pharmazeutische zusammensetzung.
EE03235B1 (et) Emulsioonvorm, selle valmistamise protsess ja kasutamine
BR9610089A (pt) Microemulsão não tóxica de óleo em água ou bicontínua processo para sua preparação e uso da mesma
CA2314934A1 (en) Use of microparticles combined with submicron oil-in-water emulsions
EP0966456A4 (en) THE ACTIVE SUBSTANCE RESISTANCE IN CANCER CHEMOTHERAPY REVERSING TAXOIDS AND PHARMACEUTICAL PREPARATIONS THEREOF
Siim et al. Scintigraphic imaging of the hypoxia marker 99mtechnetium-labeled 2, 2′-(1, 4-diaminobutane) bis (2-methyl-3-butanone) dioxime (99mTc-labeled HL-91; Prognox): noninvasive detection of tumor response to the antivascular agent 5, 6-dimethylxanthenone-4-acetic acid
CA2383600A1 (en) Method for determining viability of a myocardial segment
US6811766B1 (en) Ultrasound imaging with contrast agent targeted to microvasculature and a vasodilator drug
GB2302505A (en) Stabilisation of photosensitive materials
SE9402880D0 (sv) New peptide derivatives
GB9808582D0 (en) Improvements in or relating to contrast agents
Møller et al. Neurohumoral fluid regulation in chronic liver disease
Flynn et al. Sarafotoxin S6c elicits a non-ETA or non-ETB-mediated pressor response in the pithed rat
HUP0004362A2 (hu) Karbamazepint vagy származékait tartalmazó parenterális készítmények
WO2003072606A3 (en) Galectin-8and functional derivatives as binding agents for cd44 glycoproteins and methods of use
Suzuki et al. PERIARTERITIS NODOSA IN SPONTANEOUSLY HYPERTENSIVE RATS:–Immunohistological Study and Permeability Test–
KR900017599A (ko) 종양 치료용 약학 조성물
Evans et al. Effects of chronic delta-9-THC treatment on cardiac beta-adrenoceptors in rats
KR920002166A (ko) 주사용 리포좀 분산제를 제조하는 방법
Glover et al. Myocardial uptake of Tc-99m-NOET during adenosine hyperemia in dogs with mild to moderate coronary stenoses
Gnecchi-Ruscone et al. Ergotamine limits hyperemic myocardial blood flow in humans
DK1140195T3 (da) Olie-i-vand emulsion med beskyttende virkning mod skader på menneskeorganer fra peroxidering, samt fremstilling og anvendelse deraf

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)